MSB 10.4% $1.49 mesoblast limited

Ann: Ulcerative Colitis & Crohns Results Presented at ECCO, page-166

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35 Posts.
    lightbulb Created with Sketch. 3
    Does anyone know when we are likely to get an update on progress in the UC & Crohns study?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.